RS50245B - Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati - Google Patents

Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati

Info

Publication number
RS50245B
RS50245B YU48400A YU48400A RS50245B RS 50245 B RS50245 B RS 50245B YU 48400 A YU48400 A YU 48400A YU 48400 A YU48400 A YU 48400A RS 50245 B RS50245 B RS 50245B
Authority
RS
Serbia
Prior art keywords
gastroprotected
obtaining
same
pharmaceutical preparations
omeprazole microgranules
Prior art date
Application number
YU48400A
Other languages
English (en)
Inventor
Pascal Suplie
Patrice Debregeas
Pascal Oury
Gèrard Leduc
Original Assignee
Ethypharm,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9522415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS50245(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm, filed Critical Ethypharm,
Publication of YU48400A publication Critical patent/YU48400A/sh
Publication of RS50245B publication Critical patent/RS50245B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Omeprazol mikrogranule, od kojih svaka sadrži aktivni sloj koji sadrži aktivni princip i spoljašnji gastroprotektivni sloj koji sadrži gastroprotektivni agens, naznčene time, što su oslobođene alkalnih jedinjenja u obliku soli i što aktivni sloj sadrži jednu hidrofobnu supstancu odabranu iz silikonskih ulja. Prijava sadrži još 14 patentnih zahteva.
YU48400A 1998-01-30 1998-08-10 Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati RS50245B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9801098A FR2774288B1 (fr) 1998-01-30 1998-01-30 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (2)

Publication Number Publication Date
YU48400A YU48400A (sh) 2003-02-28
RS50245B true RS50245B (sr) 2009-07-15

Family

ID=9522415

Family Applications (1)

Application Number Title Priority Date Filing Date
YU48400A RS50245B (sr) 1998-01-30 1998-08-10 Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati

Country Status (32)

Country Link
US (1) US6551621B1 (sr)
EP (1) EP1051174B2 (sr)
JP (1) JP4286452B2 (sr)
KR (1) KR100510366B1 (sr)
CN (1) CN1114405C (sr)
AT (1) ATE232100T1 (sr)
AU (1) AU755882B2 (sr)
BG (1) BG65087B1 (sr)
BR (1) BR9814924B1 (sr)
CA (1) CA2319015C (sr)
CZ (1) CZ299192B6 (sr)
DE (1) DE69811278T3 (sr)
DK (1) DK1051174T4 (sr)
EA (1) EA002879B1 (sr)
EE (1) EE05620B1 (sr)
ES (1) ES2189232T5 (sr)
FR (1) FR2774288B1 (sr)
GE (1) GEP20032941B (sr)
HK (1) HK1032354A1 (sr)
HU (1) HU229956B1 (sr)
IL (1) IL137536A0 (sr)
IS (1) IS2866B (sr)
NO (1) NO330144B1 (sr)
NZ (1) NZ505998A (sr)
PL (1) PL200043B1 (sr)
PT (1) PT1051174E (sr)
RS (1) RS50245B (sr)
SI (1) SI1051174T2 (sr)
SK (1) SK285666B6 (sr)
TR (1) TR200002214T2 (sr)
UA (1) UA61988C2 (sr)
WO (1) WO1999038511A1 (sr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
JP5171038B2 (ja) * 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
EP2007362B1 (en) 2006-04-04 2018-09-05 KG Acquisition LLC Oral dosage forms including an antiplatelet agent and an acid inhibitor
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
AU2007311493B2 (en) * 2006-10-17 2013-01-31 Ranbaxy Laboratories Limited Multiple unit tablet compositions of benzimidazole compounds
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
ES2944568T3 (es) 2015-07-17 2023-06-22 Be Pharbel Mfg Micropartículas multicapa de liberación de compuestos farmacéuticamente activos en forma de dosificación líquida
EP3117824A1 (en) 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
FR3078630B1 (fr) 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
AU4129496A (en) * 1994-09-30 1996-04-26 Medical Security Corporation Method and system for cleaning and slip-resistant treatment of surface coverings
ES2094694B1 (es) † 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
PL186605B1 (pl) * 1995-09-21 2004-01-30 Pharma Pass Llc Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol
EP0941074B1 (en) * 1996-11-06 2004-07-21 Wockhardt Europe Limited Delayed delivery system for acid-sensitive drugs
GB9710800D0 (en) 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II

Also Published As

Publication number Publication date
NO330144B1 (no) 2011-02-21
JP2002501895A (ja) 2002-01-22
WO1999038511A1 (fr) 1999-08-05
DE69811278T3 (de) 2012-11-29
DK1051174T4 (da) 2012-10-01
HU229956B1 (hu) 2015-03-02
CN1114405C (zh) 2003-07-16
IL137536A0 (en) 2001-07-24
BG104634A (bg) 2001-02-28
EP1051174B2 (fr) 2012-07-04
ATE232100T1 (de) 2003-02-15
EP1051174A1 (fr) 2000-11-15
SI1051174T2 (sl) 2013-01-31
PL342044A1 (en) 2001-05-21
EE200000466A (et) 2002-04-15
HUP0100347A2 (hu) 2001-10-28
KR20010040502A (ko) 2001-05-15
HUP0100347A3 (en) 2002-12-28
EP1051174B1 (fr) 2003-02-05
AU755882B2 (en) 2003-01-02
BR9814924B1 (pt) 2010-07-13
YU48400A (sh) 2003-02-28
BG65087B1 (bg) 2007-02-28
SK11412000A3 (sk) 2001-04-09
NO20004654L (no) 2000-09-18
US6551621B1 (en) 2003-04-22
CA2319015C (fr) 2008-08-05
ES2189232T3 (es) 2003-07-01
KR100510366B1 (ko) 2005-08-24
CA2319015A1 (fr) 1999-08-05
EE05620B1 (et) 2013-02-15
SK285666B6 (sk) 2007-05-03
BR9814924A (pt) 2000-10-17
CN1284877A (zh) 2001-02-21
PL200043B1 (pl) 2008-11-28
TR200002214T2 (tr) 2000-12-21
CZ299192B6 (cs) 2008-05-14
ES2189232T5 (es) 2012-11-07
EA200000797A1 (ru) 2001-02-26
CZ20002709A3 (cs) 2000-12-13
GEP20032941B (en) 2003-04-25
PT1051174E (pt) 2003-06-30
AU9074898A (en) 1999-08-16
DE69811278D1 (de) 2003-03-13
HK1032354A1 (en) 2001-07-20
NZ505998A (en) 2003-11-28
DK1051174T3 (da) 2003-05-26
NO20004654D0 (no) 2000-09-18
IS2866B (is) 2014-01-15
JP4286452B2 (ja) 2009-07-01
UA61988C2 (uk) 2003-12-15
FR2774288B1 (fr) 2001-09-07
EA002879B1 (ru) 2002-10-31
SI1051174T1 (en) 2003-06-30
FR2774288A1 (fr) 1999-08-06
DE69811278T2 (de) 2003-11-27
IS5577A (is) 2000-07-25

Similar Documents

Publication Publication Date Title
RS50245B (sr) Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati
ATE303809T1 (de) Orale verabreichungsform enthaltend einen protonenpumpeninhbitor (z.b. pantoprazole)
NO20003051D0 (no) Metode for administrering av AspB28-humant insulin
DK0773025T3 (da) Nye stabile galeniske formuleringer indeholdende en syrelabil benzimidazolforbindelser, og fremgangsmåde til fremstilling
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
DK0984773T3 (da) Farmaceutisk formulering med omeprazol
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
SE8804628D0 (sv) New compounds
BG106102A (en) Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
ATE450254T1 (de) Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase
MX9305026A (es) Piridiletoxi-, piridiletilamino-, y piridilpropil-derivados de quinolina y quinazolina.
ATE236621T1 (de) Niedrig dosierte tabletten, und verfahren zur herstellung
NO20030658L (no) Fremgangsmåte for modulering av multippel ''lineage'' kinaseproteiner og undersökelse av forbindelser som modulerer multippel "lineage"kinaseproteiner
IT1304899B1 (it) Metodo e dispositivo per la somministrazione di farmaci